Instil Bio, Inc.(TIL)

Biotechnology · Dallas, TX

$6.89-0.07 (-0.94%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

Compare

EV/Sales Ratio: N/A

Name: Instil Bio, Inc. (TIL) EV/Sales Ratio — historical time series
Creator: TGMCharts

Basis: Current FMP quote-based enterprise value / four-quarter revenue. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/Sales ratio is N/A as of 2026-10-06T20:33:14.075Z.

Stored calculation inputs

Calculation as of: 2026-10-06T20:33:14.075Z.

Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 46,693,905
Total debt · period ending 2026-06-30: 3,670,000
Cash · period ending 2026-06-30: 5,541,000
TTM revenue · period ending 2026-06-30: 0

FMP input reference: 1639651ea08d8a43111aa8341d4d68762a5dc33ecadd1da8a92c037613eb041e

EV/EBITDA|P/S Ratio|Revenue|All Metrics

EV/Sales Ratio

TIL EV/Sales Ratio Chart

N/A

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2021-11-15.

TIL EV/Sales Ratio Metrics

EV/SALES RATIO

N/A

EV/SALES RATIO AVG TTM

N/A

EV/SALES RATIO AVG 3Y

N/A

EV/SALES RATIO AVG 5Y

N/A

EV/SALES RATIO AVG 10Y

N/A

EV/SALES RATIO AVG 15Y

N/A

EV/SALES RATIO AVG 20Y

N/A

CURRENT VS TTM AVG

N/A

CURRENT VS 3Y AVG

N/A

CURRENT VS 5Y AVG

N/A

CURRENT VS 10Y AVG

N/A

CURRENT VS 15Y AVG

N/A

CURRENT VS 20Y AVG

N/A

TIL Competitors' EV/Sales Ratio

TIL

Instil Bio, Inc.

Current

Market Cap

$46.69M

EV/Sales Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CELU

Celularity Inc.

vs TIL

Market Cap

$45.73M

EV/Sales Ratio

5.57x

TTM Avg

2.45x

3Y Avg

4.17x

5Y Avg

10.47x

LITS

Lite Strategy, Inc.

vs TIL

Market Cap

$47.98M

EV/Sales Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

APLM

Apollomics, Inc.

vs TIL

Market Cap

$48.53M

EV/Sales Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

HOWL

Werewolf Therapeutics, Inc.

vs TIL

Market Cap

$44.72M

EV/Sales Ratio

1.08x

TTM Avg

1.15x

3Y Avg

3.38x

5Y Avg

3.26x

SNWV

SANUWAVE Health Inc.

vs TIL

Market Cap

$44.71M

EV/Sales Ratio

1.28x

TTM Avg

4.47x

3Y Avg

4.27x

5Y Avg

5.38x

MBOT

Microbot Medical Inc.

vs TIL

Market Cap

$48.76M

EV/Sales Ratio

134.35x

TTM Avg

807.14x

3Y Avg

807.14x

5Y Avg

807.14x

TELA

TELA Bio, Inc.

vs TIL

Market Cap

$48.77M

EV/Sales Ratio

0.94x

TTM Avg

0.78x

3Y Avg

1.34x

5Y Avg

2.63x

SRTS

Sensus Healthcare, Inc.

vs TIL

Market Cap

$48.89M

EV/Sales Ratio

1.94x

TTM Avg

1.46x

3Y Avg

1.62x

5Y Avg

2.26x

POCI

Precision Optics Corporation, Inc.

vs TIL

Market Cap

$49.25M

EV/Sales Ratio

1.38x

TTM Avg

1.40x

3Y Avg

1.67x

5Y Avg

2.03x

NAME	MARKET CAP	EV/SALES RATIO	TTM	3Y	5Y
Instil Bio, Inc. (TIL)	$46.69M	N/A	N/A	N/A	N/A
Celularity Inc. (CELU)vs ›	$45.73M	5.57x	2.45x	4.17x	10.47x
Lite Strategy, Inc. (LITS)vs ›	$47.98M	N/A	N/A	N/A	N/A
Apollomics, Inc. (APLM)vs ›	$48.53M	N/A	N/A	N/A	N/A
Werewolf Therapeutics, Inc. (HOWL)vs ›	$44.72M	1.08x	1.15x	3.38x	3.26x
SANUWAVE Health Inc. (SNWV)vs ›	$44.71M	1.28x	4.47x	4.27x	5.38x
Microbot Medical Inc. (MBOT)vs ›	$48.76M	134.35x	807.14x	807.14x	807.14x
TELA Bio, Inc. (TELA)vs ›	$48.77M	0.94x	0.78x	1.34x	2.63x
Sensus Healthcare, Inc. (SRTS)vs ›	$48.89M	1.94x	1.46x	1.62x	2.26x
Precision Optics Corporation, Inc. (POCI)vs ›	$49.25M	1.38x	1.40x	1.67x	2.03x

Understanding EV/Sales

Enterprise Value (EV) = Market Cap + Total Debt - Cash

Sales = Total Revenue (TTM)

EV/Sales is commonly used because:

It works for unprofitable companies where P/E doesn't apply
Revenue is harder to manipulate than earnings
It supports comparisons across companies at different profitability stages
It is frequently used for software and other revenue-growth-focused companies

Note: EV/Sales does not include margin, debt maturity, cash conversion, or growth durability by itself.

EV/Sales Ratio Formula & Definition

EV/Sales = Enterprise Value / Revenue (TTM)

Enterprise value to sales compares total company value to revenue, useful across capital structures and for unprofitable companies.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

TIL EV/Sales Ratio History

DATE	EV/SALES RATIO
2021-11-15	40968.81x
2021-11-12	40300.35x
2021-11-11	44187.31x
2021-11-10	40770.75x
2021-11-09	42330.48x
2021-11-08	44806.25x
2021-11-05	43172.24x
2021-11-04	42553.30x
2021-11-03	42330.48x
2021-11-02	42553.30x
2021-11-01	42132.42x
2021-10-29	39532.86x
2021-10-28	38542.55x
2021-10-27	36215.33x
2021-10-26	36660.97x
2021-10-25	34531.81x
2021-10-22	34185.20x
2021-10-21	33987.14x
2021-10-20	33714.80x
2021-10-19	33937.62x
2021-10-18	33467.23x
2021-10-15	33467.23x
2021-10-14	33987.14x
2021-10-13	34209.96x
2021-10-12	33912.87x
2021-10-11	32972.07x
2021-10-08	33541.50x
2021-10-07	33987.14x
2021-10-06	32600.71x
2021-10-05	33690.05x
2021-10-04	34259.47x
2021-10-01	36438.15x
2021-09-30	33355.82x
2021-09-29	39235.77x
2021-09-28	46242.20x
2021-09-27	46737.35x
2021-09-24	46266.95x
2021-09-23	42974.18x
2021-09-22	42330.48x
2021-09-21	41043.08x
2021-09-20	39409.07x
2021-09-17	38022.64x
2021-09-16	35076.48x
2021-09-15	36710.48x
2021-09-14	29951.63x
2021-09-13	33789.08x
2021-09-10	35324.05x
2021-09-09	37973.13x
2021-09-08	37651.28x
2021-09-07	40894.53x
2021-09-03	42280.97x
2021-09-02	39879.47x
2021-09-01	36339.12x
2021-08-31	35769.69x
2021-08-30	35546.87x
2021-08-27	38592.07x
2021-08-26	37477.97x
2021-08-25	35794.45x
2021-08-24	33071.10x
2021-08-23	31882.73x
2021-08-20	30471.55x
2021-08-19	28688.99x
2021-08-18	28862.30x
2021-08-17	29184.15x
2021-08-16	29332.69x
2021-08-13	30025.91x
2021-08-12	16043.98x
2021-08-11	15797.46x
2021-08-10	16016.59x
2021-08-09	16619.20x
2021-08-06	16947.90x
2021-08-05	15537.24x
2021-08-04	15290.71x
2021-08-03	15879.63x
2021-08-02	14633.32x
2021-07-30	14126.57x
2021-07-29	15715.28x
2021-07-28	16605.50x
2021-07-27	16002.89x
2021-07-26	18454.43x
2021-07-23	20111.61x
2021-07-22	20084.22x
2021-07-21	20234.88x
2021-07-20	20029.44x
2021-07-19	19070.74x
2021-07-16	19399.44x
2021-07-15	19385.74x
2021-07-14	19358.35x
2021-07-13	20015.74x
2021-07-12	20823.79x
2021-07-09	20878.58x
2021-07-08	20303.36x
2021-07-07	21015.53x
2021-07-06	20796.40x
2021-07-02	21015.53x
2021-07-01	20919.66x
2021-06-30	19974.66x
2021-06-29	18646.17x
2021-06-28	19796.61x
2021-06-25	19536.39x
2021-06-24	20207.49x
2021-06-23	18002.47x
2021-06-22	18344.86x
2021-06-21	19043.35x
2021-06-18	18194.21x
2021-06-17	18248.99x
2021-06-16	17345.07x
2021-06-15	17838.12x
2021-06-14	16167.24x
2021-06-11	16797.24x
2021-06-10	16454.85x
2021-06-09	14482.66x
2021-06-08	14482.66x
2021-06-07	15372.89x
2021-06-04	14825.06x
2021-06-03	14797.67x
2021-06-02	15701.59x
2021-06-01	17071.16x
2021-05-28	17892.90x
2021-05-27	17755.95x
2021-05-26	17002.68x
2021-05-25	16797.24x
2021-05-24	18207.91x
2021-05-21	18728.34x
2021-05-20	19057.04x
2021-05-19	17180.73x
2021-05-18	21234.67x
2021-05-17	20070.53x
2021-05-14	18166.82x
2021-05-13	13429.52x
2021-05-12	12593.35x
2021-05-11	13345.91x
2021-05-10	14739.52x
2021-05-07	15854.41x
2021-05-06	15334.12x
2021-05-05	17294.47x
2021-05-04	17777.59x
2021-05-03	17833.33x
2021-04-30	17322.34x
2021-04-29	16021.64x
2021-04-28	14999.66x
2021-04-27	14256.40x
2021-04-26	13996.26x
2021-04-23	13708.24x
2021-04-22	13856.90x
2021-04-21	14609.45x
2021-04-20	15724.34x
2021-04-19	15427.03x
2021-04-16	15900.86x
2021-04-15	15603.56x
2021-04-14	16829.93x
2021-04-13	17628.94x
2021-04-12	18632.34x
2021-04-09	18715.95x
2021-04-08	18911.06x
2021-04-07	19301.27x
2021-04-06	20880.70x
2021-04-05	21131.55x
2021-04-01	20258.22x
2021-03-31	21549.63x
2021-03-30	20769.21x
2021-03-29	22841.04x
2021-03-26	23389.20x
2021-03-25	20759.92x
2021-03-24	20899.28x
2021-03-23	22590.19x
2021-03-22	23147.64x
2021-03-19	22813.17x

Related Metrics

EV/EBITDA P/S Ratio Revenue All Metrics